Found 5 matching trials
Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDS PHASE1 To characterize the safety and tolerability of 1) MBG453 as a single agent ...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
Anti-PD-1 Antibody Alone or in Combination With Decitabine/Chemotherapy in Relapsed or Refractory Malignancies PHASE1 The purpose of this study is to assess the feasibility, safety, and efficac...
Show More Location
Biotherapeutic Department of Chinese PLA General Hospital
Learn More & Join Trial
Two Stage Study of Combination of Chemotherapy, SHR-1210 and/or Decitabine for Relapsed/Refractory PMBCLs PHASE1 This is a two stage, Phase I/II clinical trial for patients with relapsed o...
Show More Location
Biotherapeutic Department and Pediatrics Department of Chinese PLA General Hospital
Learn More & Join Trial
Decitabine and Anti-PD-1 in R/R DLBCL PHASE2 Patients with relapsed/refractory diffuse large B cell lymphoma with extran...
Show More Learn More & Join Trial
Phase I/II Clinical Study of Decitabine Combined With TQB2450 Injection or Decitabine + Anlotinib Combined With TQB2450 Injection in the Treatment of PD-1 Monoclonal Antibody-resistant Digestive System Tumors PHASE1 This clinical study focused on patients with digestive system tumors resist...
Show More Location
Multiple Locations
Learn More & Join Trial